To provide the US Public Affairs and Patient Advocacy (US PA&PA) fellow with necessary hands-on experience, knowledge, and skills to make a positive impact on patient health outcomes.
The US PA&PA team partners with US patient advocacy groups and professional societies to champion issues critical to patients. Coordinating the company’s approach with external advocates requires active engagement and extensive collaboration with various internal, cross-functional teams across all parts of the company.
As an active member of the healthcare ecosystem, Sanofi is dedicated to the needs of patients and finding collaborative solutions. Our goal is to be a partner who listens, acts, and leads to improve patient health, accelerate medical innovation, and facilitate access to medicines and vaccines. US PA&PA bridges the insights, knowledge, and resources of both the external advocacy community and within Sanofi to support advocacy initiatives that matter most to patients.
During this two-year program, the fellow will:
Build and maintain external advocacy relationships by liaising with US patient groups, medical and professional societies, health foundations, and other stakeholders in the advocacy community to inform internal decision-making and patient-centric initiatives.
Enhance their understanding of the US healthcare system through leadership on cross-functional projects that aim to develop timely, evidence-based, patient-centric solutions.
Develop and enhance critical skills while working with colleagues across Corporate Affairs, R&D, medical, and commercial teams to manage partnerships and projects in a global, diversified healthcare solutions company.
Strategically network and build meaningful relationships with internal leadership and external advocacy leaders across the healthcare ecosystem.
Core experience will be within the Sanofi Specialty Care therapeutic areas (Rare Blood Disorders, Rare Diseases, Immunology, Neurology and Oncology). Additional opportunities to gain experience within Vaccines and the General Medicines (Type 1 Diabetes, Cardiometabolic and Transplant) therapeutic areas, if desired.
Outside of their experiences in US Public Affairs & Patient Advocacy, the Fellow may also have rotational or project experience(s) in other areas of the company to further enhance their professional development, including Global Public Affairs, Reimbursement & Public Policy, Science Policy, Federal and State Government Relations, Communications and Corporate Social Responsibility, and Market Access.
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 2, 2023. Applicants must upload the following application materials to the online portal by November 17, 2023:
Letter of intent
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than November 27, 2023, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Burbank, CA. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 13, 2023.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Sanofi’s global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology. Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine for millions of people around the world.